CITIUS PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSat, 20 Jun 2026 15:08:45 +0200https://images.finanzen.net/images/finanzen_net_neu.gifCITIUS PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netCitius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business UpdateTue, 23 Dec 2025 22:30:00 +0100https://www.finanzen.net/nachricht/aktien/citius-pharmaceuticals-inc-reports-fiscal-year-2025-financial-results-and-provides-business-update-15377928

Subsidiary, Citius Oncology, launches cancer immunotherapy, LYMPHIR™, in the U.S. in December 2025

]]>https://www.finanzen.net/nachricht/aktien/citius-pharmaceuticals-inc-reports-fiscal-year-2025-financial-results-and-provides-business-update-15377928Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business UpdateTue, 23 Dec 2025 22:30:00 +0100https://www.finanzen.net/nachricht/aktien/citius-oncology-inc-reports-fiscal-year-2025-financial-results-and-provides-business-update-15377929

Cancer Immunotherapy, LYMPHIR™, launched in the U.S. in December 2025

Completed $36 million ...

]]>https://www.finanzen.net/nachricht/aktien/citius-oncology-inc-reports-fiscal-year-2025-financial-results-and-provides-business-update-15377929